Cambridge Investment Research Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.82M Buy
16,098
+10,304
+178% +$1.02M ﹤0.01% 1762
2026
Q1
$545K Sell
5,794
-3,074
-35% -$307K ﹤0.01% 2716
2025
Q4
$876K Buy
+8,868
New +$858K ﹤0.01% 2205
2021
Q4
– Sell
-2,961
Closed -$204K – 3226
2021
Q3
$204K Buy
2,961
+51
+2% +$3.88K ﹤0.01% 2800
2021
Q2
$245K Buy
2,910
+101
+4% +$8.42K ﹤0.01% 2639
2021
Q1
$228K Buy
+2,809
New +$240K ﹤0.01% 2503
2020
Q2
– Sell
-3,813
Closed -$279K – 2484
2020
Q1
$279K Buy
3,813
+1,286
+51% +$97.1K ﹤0.01% 1721
2019
Q4
$221K Buy
+2,527
New +$216K ﹤0.01% 2137
2019
Q2
– Sell
-2,351
Closed -$202K – 2275
2019
Q1
$202K Buy
+2,351
New +$191K ﹤0.01% 2068
2017
Q4
– Sell
-3,149
Closed -$368K – 2128
2017
Q3
$368K Buy
+3,149
New +$398K ﹤0.01% 1434
2015
Q1
– Sell
-3,062
Closed -$224K – 1429
2014
Q4
$224K Buy
+3,062
New +$200K 0.01% 1155

Other funds holding INCY

Cambridge Investment Research Advisors's INCY Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Incyte (INCY) stake by 178% in Q2 2026, buying an estimated $1.02M and bringing the position to 16,098 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Cambridge Investment Research Advisors first reported a position in INCY in Q4 2014 and has held it in 11 quarters since. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Cambridge Investment Research Advisors held 16,098 shares of Incyte worth $1.82M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 10,304 Incyte shares in Q2 2026, an estimated $1.02M.
  • Incyte made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1762 holding.
  • Cambridge Investment Research Advisors first reported a position in Incyte in Q4 2014 and has held it in 11 quarters since.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.